Skip to content

Understanding Your Diagnostic Laboratory Test: A Patient's Guide

Published: August 9, 2026Updated: August 16, 2026

A genetic test that analyzes the BBS1 gene to identify mutations associated with Bardet-Biedl syndrome.

Quick summary

{"This test looks for specific changes (mutations) in the BBS1 gene","It helps diagnose Bardet-Biedl syndrome, a rare genetic disorder","A blood sample is typically used for this genetic analysis","Results help guide medical management and family planning decisions","Genetic counseling is often recommended before and after testing"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
41743-6
Short code
BBS1TM
Synonyms
BBS1 gene Mut Anl Bld/T
Category
chemistry
Sample
whole-blood
Container
EDTA (lavender/purple-top) blood collection tube for whole blood; sterile container for tissue samples
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
molgen
CPT
81403
SNOMED
444863008
Specimen volume
3-5 mL whole blood in EDTA tube; 5-10 mg tissue in sterile container
Stability
Whole blood: stable for 7 days at 2-8°C; ambient (15-25°C) up to 48 hours. Tissue: stable for 24 hours at 2-8°C. Long-term storage: -20°C or -80°C for DNA extraction.
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
168–720 hours
Order
routine

This test is a laboratory analysis performed on a sample of your blood, urine, or other body fluid to help your health care provider evaluate how well your body is functioning and look for possible signs of illness or infection.

The BBS1 gene targeted mutation analysis is a specialized genetic test that examines the BBS1 gene for specific mutations known to cause Bardet-Biedl syndrome (BBS). Bardet-Biedl syndrome is a rare inherited disorder that affects multiple body systems. This test uses molecular genetics methods to look for changes in the DNA sequence of the BBS1 gene.

Your provider may order this test to screen for disease before symptoms appear, to help diagnose the cause of symptoms you are already experiencing, to monitor a condition you have been diagnosed with, or to check how well your current treatment is working.

This test is primarily performed to help diagnose Bardet-Biedl syndrome in individuals who show symptoms of the disorder. Symptoms may include obesity, vision problems (retinal degeneration), extra fingers or toes (polydactyly), kidney abnormalities, and learning difficulties. The test may also be used for carrier testing in families with a known BBS1 mutation and for prenatal diagnosis in high-risk pregnancies.

A trained member of our staff will collect a small sample, most often by drawing blood from a vein in your arm with a thin needle, though some tests use a urine sample or a simple finger stick. The sample is sent to the laboratory, and results are usually ready within a few days.

A healthcare provider will collect a blood sample from a vein in your arm. In some cases, a tissue sample may also be used. The sample is then sent to a specialized laboratory where technicians extract DNA and analyze the BBS1 gene for specific mutations using advanced molecular genetics techniques. The results are typically available within a few weeks.

Your results are compared with established reference ranges that show what is typical for healthy people. Values within the normal range generally suggest the condition being tested for is not present, while values that are higher or lower than expected may indicate a health issue that needs closer attention. Your provider will review the findings with you, explain what they mean in your situation, and discuss any follow-up testing or treatment that may be needed.

A positive result means that a mutation was found in the BBS1 gene, which supports a diagnosis of Bardet-Biedl syndrome. A negative result means no known BBS1 mutation was found, but it does not completely rule out Bardet-Biedl syndrome, as other genes can also cause the condition. Your healthcare provider and possibly a genetic counselor will help interpret your specific results.

This test is very safe. You may feel a brief sting when the needle is inserted, and the puncture site may be slightly sore or bruised, with minor bleeding that stops quickly. Serious complications such as infection are rare. Tell your provider if you have a bleeding disorder, take blood thinners, or feel faint around needles so appropriate precautions can be taken.

The risks associated with this test are minimal and similar to routine blood draws. You may experience slight pain, bruising, or dizziness. There are no physical risks from the genetic testing itself, but some patients may experience emotional distress or anxiety while waiting for results.

Reference range

No disease-associated (pathogenic or likely pathogenic) BBS1 mutations detected. Interpretation considers known Bardet-Biedl syndrome-associated variants in the BBS1 gene (e.g., M390R). Reference genome: GRCh37/hg19 or GRCh38/hg38.N/A

Specimen: whole-blood

No special patient preparation or fasting required. Genetic counseling is recommended before and after testing. Informed consent may be required per institutional policy. Patient should provide relevant clinical and family history information.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

The BBS1 gene mutation analysis is clinically significant for confirming a diagnosis of Bardet-Biedl syndrome, which enables early intervention and appropriate management of associated health problems. Early diagnosis allows for timely treatment of vision loss, kidney issues, and other complications. Knowing the specific genetic mutation can also help predict disease progression and guide family planning decisions. Additionally, identifying BBS1 mutations allows for accurate genetic counseling and carrier testing for family members.

Frequently asked questions

Who should consider this test?
Individuals showing symptoms of Bardet-Biedl syndrome, such as obesity, vision loss, extra digits, or kidney problems, may benefit from this test. It is also recommended for individuals with a family history of BBS who are considering having children.
Do I need to fast before this test?
No, fasting is not required for this genetic blood test. You can eat and drink normally before the sample is collected.
How long does it take to get results?
Results typically take 2-4 weeks to process, as the analysis requires specialized molecular genetics techniques. Your healthcare provider will contact you when results are available.
Will my insurance cover this test?
Coverage varies by insurance provider and individual policy. Many insurers cover genetic testing when it is medically necessary for diagnosis. It is recommended to check with your insurance company beforehand to understand your coverage and any out-of-pocket costs.
Can this test detect all types of Bardet-Biedl syndrome?
No, this test specifically looks for mutations in the BBS1 gene. Bardet-Biedl syndrome can also be caused by mutations in other genes (BBS2, BBS4, BBS5, BBS7, BBS9, BBS18, etc.). If BBS1 testing is negative but clinical suspicion remains high, additional gene testing may be recommended.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy